Table 1.
Characteristics of the Included Study of Li-ESWT for ED Patients.
| Study | Year | Country | Follow-up | Weeks of treatment | No. of shocks per treatment | Total shocks | Sample | IIEF-EF score before treatment | Change in IIEF-EF score | EHS | Type of ED | Type of machine | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| treatment | control | treatment | control | treatment | control | treatment | control | |||||||||
| Vardi, Appel, Kilchevsky, and Gruenwald (2012) | 2012 | Israel | 1mo | 9 | 1500 | 18000 | 40 | 20 | 12.6 ± 0.75 | 11.5 ± 0.86 | 6.7 | 3.0 | 31 | 7 | vasculogenic ED | Omnispec ED1000 |
| Yee et al. (2014) | 2014 | China | 4wks | 9 | 1500 | 18000 | 30 | 28 | 10.2 ± 3.8 | 10.2 ± 3.8 | 5.3 ± 5.5 | 3.8 ± 3.6 | - | - | vasculogenic ED | Omnispec ED1000 |
| Olsen et al. (2015) | 2015 | Denmark | 5wks | 5 | 3000 | 15000 | 51 | 54 | - | - | - | - | 29 | 5 | vasculogenic ED | Storz |
| Srini et al. (2015) | 2015 | India | 12mos | 9 | 1500 | 18000 | 60 | 17 | 9.5 | 9.2 | 12.5 | 1.4 | 47 | 0 | vasculogenic ED | Omnispec ED1000 |
| Kitrey et al. (2016) | 2016 | Israel | 4wks | 9 | 1500 | 18000 | 37 | 18 | 7(IQR) | 8(IQR) | 5 | 0 | 20 | 0 | vasculogenic ED | Omnispec ED1000 |
| Kalyvianakis and Hatzichristou (2017) | 2017 | Greece | 12mos | 9 | 1500 | 18000 | 30 | 16 | 13.8 ± 3.6 | 14.6 ± 3.4 | 18.46 ± 3.6(1m) | 16.43 ± 3.5(1m) | - | - | vasculogenic ED | Omnispec ED1000 |
| Fojecki et al. (2017) | 2017 | Denmark | 4wks | 9 | 600 | 3000 | 58 | 63 | 10.9 | 11.5 | 2.2 | 2.5 | - | - | vasculogenic ED | FBL10 |
Note. Li-ESWT = low-intensity extracorporeal shockwave therapy; IIEF-EF = International Index of Erectile Function erectile function domain; ED = erectile dysfunction; EHS = Erection Hardness score; IQR = interquartile range; mo = month; wk = week.